3 citations · 3 across the 3 of their papers we have counts for
3 papers
Analysis and sample size calculation within the responder stratified exponential survival model
Samuel Kilian, Johannes Krisam, Meinhard Kieser
The primary endpoint in oncology is usually overall survival, where differences between therapies may only be observable after many years. To avoid withholding of a promising thera…
Enhancing single-arm phase II trials by inclusion of matched control patients
Johannes Krisam, Dorothea Weber, Richard F. Schlenk +1
When a novel treatment has successfully passed phase I, different options to design subsequent phase II trials are available. One approach is a single-arm trial, comparing the resp…
Efficient adaptive designs for clinical trials of interventions for COVID-19
Nigel Stallard, Lisa Hampson, Norbert Benda +14
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clin…